Syncope, a temporary loss of consciousness due to inadequate cerebral blood flow, is a common clinical presentation. Its multifaceted etiology, ranging from benign to life-threatening, makes diagnosis and management challenging.
Three primary categories of syncope are reflex (neurally mediated), orthostatic hypotension, and cardiac syncope. Reflex syncope is often triggered by emotional distress or orthostatic stress. Orthostatic hypotension is due to either autonomic failure or volume depletion. Cardiac syncope could be either arrhythmic or structural heart disease.
Initial evaluation should include a detailed history and physical examination, focusing on precipitating events, prodromal symptoms, and family history of sudden death. Initial testing should include an ECG. Further testing, such as echocardiography or tilt-table testing, should be guided by clinical suspicion based on initial evaluation.
Management should target the underlying cause. Reflex syncope often responds to education, reassurance, and avoidance of triggers. Orthostatic hypotension may require volume expansion, compression stockings, or pharmacotherapy. Cardiac syncope may require pacemakers, implantable cardioverter-defibrillators, or specific treatments for heart disease.
Risk stratification can guide management. High-risk features include advanced age, history of heart disease, abnormal ECG, and syncope during exertion or supine. Patients with these features require urgent evaluation and intervention.
Syncope presents a diagnostic challenge due to its varied etiology. An organized approach, from understanding its etiology to implementing effective management strategies, is crucial. Risk stratification can aid in this process, ensuring that high-risk patients receive appropriate and timely interventions. Ongoing research will continue to refine our understanding and management of this complex condition.
1.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
2.
Efficacy and safety of intravenous chemotherapy in children with intraocular retinoblastoma
3.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
4.
Treating Depression: Crucial for Recovery From Fibromyalgia
5.
In postmenopausal women with hormone receptor-positive tumors, obesity increases the risk of breast cancer recurrence.
1.
Empowering Oncology with Data: Cloud Security, Real-World Evidence, and Clinical Insights
2.
Immune Regulation of Blood Cell Development
3.
Exploring the Effects of Radiation Therapy on Cystitis: A Journey to Better Health
4.
Transformative Frameworks in Oncology for Better Care
5.
Liposomal Doxorubicin and Mitomycin in Modern Cancer Treatment
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Targeting Oncologic Drivers: A New Approach to Lung Cancer Treatment
2.
Newer Immunotherapies for Myeloma- A Comprehensive Overview
3.
Understanding the causes of anemia in adults beyond nutritional deficiencies
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation